Article
29 Oct 2025
Federal Circuit Affirms-in-Part And Vacates-In-Part PTAB Unpatentability Findings Based On Claim Construction
AUTHORS CONTENT
Article
27 Dec 2022
Board Reaffirms That Assignor Estoppel Does Not Bar Assignor From Filing IPR Petition
Article
14 Apr 2022
Considerations For Protecting Trade Secrets In FDA Correspondence
Article
03 Aug 2021
Clarifying Pleading Requirements For Patent Cases
Article
12 Sep 2019
35 U.S.C. § 314(d) Prevents Appeal Of PTAB's Decision To Deny Institution Upon Reconsideration
Article
01 Apr 2019
FDA Procedures For Handling Requests For Nonproprietary Name Suffix Review For Biological Products Newly Licensed Under Section 351 Of The PHS Act
Article
29 Jan 2019
FDA Draft Guidance On Common Issues In Drug Development For Rare Diseases
Article
08 Jan 2019
CAFC Holds ITC Must Grant Relief Against Defaulting Respondents Under 19 U.S.C. § 1337(G)(1) In Laerdal Medical Corp. v. ITC
Article
03 Jan 2019
Statute Requires ITC Grant Relief Against Defaulting Respondents, Subject To Public Interest
Article
28 Dec 2018
First Revision To Questions And Answers On Biosimilar Development
Article
17 Dec 2018
FDA Guidance On Post-Complete Response Letter Meetings Between FDA And ANDA Applicants Under GDUFA
Article
29 Nov 2018
Illuminating Evidentiary Considerations For Reasonable Royalties
Article
08 Oct 2018
FDA Final Guidance On Content And Format Of ANDA Applications